Skip to main content
SpringerLink
Log in

Expression Profiling of Pancreatic Ductal Adenocarcinoma

  • Chapter
Expression Profiling of Human Tumors

  • 79 Accesses

Abstract

Pancreatic cancer is a uniquely challenging cancer. First, it is a deadly cancer. Pancreatic cancer is the fourth leading cause of cancer death in men and in women, and, despite advances in the treatment of other types of cancer, pancreatic cancer continues to have one of the highest mortality rates of any malignancy. Each year in the U.S. approx 29,000 patients are diagnosed with pancreatic cancer, and approx 29,000 will die of their disease (1). The poor prognosis for patients with pancreatic cancer is, in large part, due to the fact that almost all patients are diagnosed at an advanced stage of disease, as no known tumor markers exist that could be used to screen for pancreatic cancer at an earlier, potentially curative stage. This is a particular problem for those patients with a strong familial history of pancreatic cancer, who may have up to a 57-fold greater risk of developing pancreatic cancer in their lifetime (2,3). Second, even when a mass caused by a pancreatic cancer is identified, it can be very difficult to establish a definitive diagnosis. Deadly infiltrating adenocarcinomas of the pancreas can be so well differentiated that it can be difficult, and even at times impossible, to distinguish cancer from reactive changes histologically. Third, even when the diagnosis can be firmly established, pancreatic cancer simply does not respond to current chemotherapeutic or radiation therapies. Perhaps more than any other tumor type, a better understanding of the gene expression of pancreatic cancer is urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. (2001) Cancer Statistics, 2001. CA Cancer J. Clin. 51, 16–36.

    Article  Google Scholar 

  2. Tersmette, A. C., Petersen, G. M., Offerhaus, G. J. A., et al. (2001) Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin. Cancer Res. 7, 738–744.

    PubMed  CAS  Google Scholar 

  3. Giardiello, F. M., Welsh, S. B., Hamilton, S. R., et al. (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med. 316, 1511–1514.

    Article  PubMed  CAS  Google Scholar 

  4. Wilentz, R. E., Geradts, J., Maynard, R., et al. (1998) Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression. Cancer Res. 58, 4740–4744.

    PubMed  CAS  Google Scholar 

  5. Wilentz, R. E., Iacobuzio-Donahue, C. A., Argani, P., et al. (2000) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60, 2002–2006.

    PubMed  CAS  Google Scholar 

  6. Hruban, R. H., Adsay, N. V., Albores-Saavedra, J., et al. (2001) Pancreatic intraepithelial neoplasia (Panin): a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 25, 579–586.

    Article  PubMed  CAS  Google Scholar 

  7. Hruban, R. H., Wilentz, R. E., and Kern, S. E. (2000) Genetic progression in the pancreatic ducts. Am. J. Pathol. 156, 1821–1825.

    Article  PubMed  CAS  Google Scholar 

  8. Redston, M. S., Caldas, C., Seymour, A. B., et al. (1994) p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res. 54, 3025–3033.

    Google Scholar 

  9. Schutte, M., Hruban, R. H., Geradts, J., et al. (1997) Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res. 57, 31263130.

    Google Scholar 

  10. Hruban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J. A., et al. (1993) K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am..1. Pathol. 143, 545–554.

    Google Scholar 

  11. Wilentz, R. E., Su, G. H., Dai, J. L., et al. (2000) Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic: a new marker of DPC4 inactivation. Am. J. Pathol. 156, 37–43.

    Article  PubMed  CAS  Google Scholar 

  12. Ellenrieder, V., Hendler, S. F., Ruhland, C., Boeck, W., Adler, G., and Gress, T. M. (2001) TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int. J. Cancer 93, 204–211.

    Article  PubMed  CAS  Google Scholar 

  13. Ebert, M., Yokoyama, M., Friess, H., Kobrin, M. S., Buehler, M. W., and Korc, M. (1995) Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int. J. Cancer 62, 529–535.

    Article  PubMed  CAS  Google Scholar 

  14. Friess, H., Yamanaka, Y., Buehler, M., et al. (1993) Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res. 53, 2704–2707.

    PubMed  CAS  Google Scholar 

  15. Goggins, M., Schutte, M., Lu, J., et al. (1996) Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56, 5360–5364.

    Google Scholar 

  16. Pour, P. M. and Schmied, B. (1999) The link between exocrine pancreatic cancer and the endocrine pancreas. Int. J. Pancreatol. 25, 77–87.

    Article  PubMed  CAS  Google Scholar 

  17. Rao, M. S., Yeldandi, A. V., and Reddy, J. K. (1990) Stem cell potential of ductular and periductular cells in the adult rat pancreas. Cell Differ. Dey. 29, 155–163.

    Article  CAS  Google Scholar 

  18. Solcia, E., Capella, C., and Klöppel, G. (1997) Atlas of Tumor Pathology: Tumors of the Pancreas. 3rd ed. Armed Forces Institute of Pathology, Washington, D.C.

    Google Scholar 

  19. Balague, C., Audie, J. P., Porchet, N., and Real, F. X. (1995) In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology 109, 953–964.

    Google Scholar 

  20. Shimizu, M., Saitoh, Y., Ohyanagi, H., and Itoh, H. (1990) Immunohistochemical staining of pancreatic cancer with CA19–9, KM01, unabsorbed CEA, and absorbed CEA. Arch. Pathol. Lab. Med. 114, 195–200.

    PubMed  CAS  Google Scholar 

  21. Terada, T., Ohta, T., Sasaki, M., Nakanuma, Y., and Kim, Y. S. (1996) Expression of MUC apomucins in normal pancreas and pancreatic tumours. J. Pathol. 180, 160–165.

    Article  PubMed  CAS  Google Scholar 

  22. Ritts, R. E. and Pitt, H. A. (1998) CA19–9 in pancreatic cancer. Surg. Clin. N. Am. 7, 93–101.

    CAS  Google Scholar 

  23. Ross, D. T., Scherf, U., Eisen, M. B., et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24, 227–235.

    Article  PubMed  CAS  Google Scholar 

  24. Iacobuzio-Donahue, C. A., Ryu, B., Hruban, R. H., and Kern, S. E. (2002) Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neo-plastic cells at the site of primary invasion. Am. J. Pathol. 160, 91–99.

    Google Scholar 

  25. Ryu, B., Jones, J., Hollingsworth, M. A., Hruban, R. H., and Kern, S. E. (2001) Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res. 61, 1833–1838.

    PubMed  CAS  Google Scholar 

  26. Hahn, S. A., Seymour, A. B., Hogue, A. T. M. S., et al. (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 55, 4670–4675.

    PubMed  CAS  Google Scholar 

  27. Ryu, B., Jones, J., Hollingsworth, M. A., Hruban, R. H., and Kern, S. E. (2002) Relationships and identification of differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res. 62, 5351–5357.

    Google Scholar 

  28. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. (1995) Serial analysis of gene expression. Science 270, 484–487.

    Google Scholar 

  29. Zhou, W., Sokoll, L. J., Bruzek, D. J., et al. (1998) Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol. Biomarkers Prey. 7, 109–112.

    Google Scholar 

  30. Rosty, C., Ueki, T., Argani, P., et al. (2002) Overexpression of S l 00A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol. 160, 45–50.

    Article  PubMed  CAS  Google Scholar 

  31. Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., et al. (2003) Exploration of global gene expression of pancreatic adenocarcinoma by cDNA microarray analysis. Am. J. Pathol.,in press.

    Google Scholar 

  32. Heiskala, M., Peterson, P. A., and Yang, Y. (2001) The roles of claudin superfamily proteins in paracellular transport. Traffic 2, 93–98.

    Article  PubMed  CAS  Google Scholar 

  33. Kikkawa, Y., Sanzen, N., Fujiwara, H., Sonnenberg, A., and Sekiguchi, K. (2000) Integrin binding specificity of laminin-10/11: laminin-10/11 are recognized by alpha 3 beta 1, alpha 6 beta 1 and alpha 6 beta 4 integrins. J. Cell Sci. 113, 869–876.

    PubMed  CAS  Google Scholar 

  34. Schussler, M. H., Skoudy, A., Ramaekers, F., and Real, F. X. (1992) Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am. J. Surg. Pathol. 140, 559–568.

    CAS  Google Scholar 

  35. DiGiuseppe, J. A., Redston, M. S., Yeo, C. J., Kern, S. E., and Hruban, R. H. (1995) p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am. J. Pathol. 147, 884–888.

    Google Scholar 

  36. Sparks, A. B., Morin, P. J., Vogelstein, B., and Kinzler, K. W. (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130–1134.

    PubMed  CAS  Google Scholar 

  37. Ruse, M., Lambert, A., Robinson, N., Ryan, D., Shon, K. J., and Eckert, R. L. (2001) S l 00A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry 40, 3167–3173.

    Google Scholar 

  38. Ellenrieder, V., Alber, B., Lacher, U., et al. (2000) Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer 85, 14–20.

    Article  PubMed  CAS  Google Scholar 

  39. Iacobuzio-Donahue, C. A., Maitra, A., Shen-Ong, G. L., et al. (2002) Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol. 160, 1239–1249.

    Google Scholar 

  40. Morita, K., Furuse, M., Fujimoto, K., and Tsukita, S. (1999) Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA 96, 511–516.

    Article  PubMed  CAS  Google Scholar 

  41. Carrio, M., Romagosa, A., Mercade, E., et al. (1999) Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene. Gene Ther. 6, 547–553.

    Article  PubMed  CAS  Google Scholar 

  42. Ripani, E., Sacchetti, A., Corda, D., and Alberti, S. (1998) Human Trop-2 is a tumor-associated calcium signal transducer. Int. J. Cancer 76, 671–676.

    Article  PubMed  CAS  Google Scholar 

  43. Namima, M., Takeuchi, K., Watanabe, Y., et al. (1998) Localization of GTPase-activating protein-(GAP) like immunoreactivity in mouse cerebral regions. Mol. Chem. Neuropathol. 35, 157–172.

    Article  PubMed  CAS  Google Scholar 

  44. Donato, R. (2001) 5100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637–668.

    Google Scholar 

  45. Tseng, Y., Fedorov, E., McCaffery, J. M., Almo, S. C., and Wirtz, D. (2001) Micro-mechanics and ultrastructure of actin filament networks crosslinked by human fascin: a comparison with alpha-actinin. J. Mol. Biol. 310, 351–366.

    Article  PubMed  CAS  Google Scholar 

  46. Goldstein, N. S. and Bassi, D. (2001) Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Am. J. Clin. Pathol. 115, 695–702.

    Article  PubMed  CAS  Google Scholar 

  47. Lai, F., Fernald, A. A., Zhao, N., and Le Beau, M. M. (2000) cDNA cloning, expression pattern, genomic structure and chromosomal location of RAB6KIFL, a human kinesin-like gene. Gene 248, 117–125.

    Google Scholar 

  48. Sato, T. K., Overduin, M., and Emr, S. D. (2001) Location, location, location: membrane targeting directed by PX domains. Science 294, 1881–1885.

    Article  PubMed  CAS  Google Scholar 

  49. Schwartz, M. A. (2001) Integrin signaling revisited. Trends Cell Biol. 11, 466–470.

    Article  PubMed  CAS  Google Scholar 

  50. Tanner, M., Jarvinen, P., and Isola, J. (2001) Amplification of HER-2/neu and topoisomerase Ilalpha in primary and metastatic breast cancer. Cancer Res. 61, 5345–5348.

    Google Scholar 

  51. Ikeda, M., Yu, W., Hirai, M., et al. (2000) cDNA cloning of a novel bHLH-PAS transcription factor superfamily gene, BMAL2: its mRNA expression, subcellular distribution, and chromosomal localization. Biochem. Biophys. Res. Commun. 275, 493–502.

    Google Scholar 

  52. Downing, J. R. (2001) AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia. Leukemia 15, 664–665.

    Article  PubMed  CAS  Google Scholar 

  53. Hosoi, Y. and Kapp, L. N. (1994) Expression of a candidate ataxia-telangiectasia group D gene in cultured fibroblast cell lines and human tissues. Int. J. Radiat. Biol. 66 (6 Suppl), S71 – S76.

    Article  PubMed  CAS  Google Scholar 

  54. Gress, T. M., Muller-Pillasch, F., Lerch, M. M., et al. (1994) Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. Z. Gastroenterol. 32, 221–225.

    PubMed  CAS  Google Scholar 

  55. Dafforn, T. R., Della, M., and Miller, A. D. (2001) The molecular interactions of heat shock protein 47 (Hsp47) and their implications for collagen biosynthesis. J. Biol. Chem. 276, 49,310–49, 319.

    Google Scholar 

  56. Rosty, C., Christa, L., Kuzdzal, S., et al. (2002) Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated-protein I (HIP/PAP-1) as a biomarker for pancreatic adenocarcinoma by protein biochip technology. Cancer Res. 62, 1868–1875.

    PubMed  CAS  Google Scholar 

  57. Tascilar, M., Offerhaus, G. J., Altink, R., et al. (2001) Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am. J. Clin. Pathol. 116, 831–837.

    Article  PubMed  CAS  Google Scholar 

  58. Jaffee, E. M., Hruban, R. H., Biedrzycki, B., et al. (2001) Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J. Clin. Oncol. 19, 145–156.

    Google Scholar 

  59. Jaffee, E. M., Schutte, M., Gossett, J., et al. (1998) Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4, 194–203.

    PubMed  CAS  Google Scholar 

  60. McDevitt, M. R., Ma, D., Lai, L. T., et al. (2001) Tumor therapy with targeted atomic nanogenerators. Science 294, 1537–1540.

    Google Scholar 

  61. Argani, P., Rosty, C., Reiter, R. E., et al. (2001) Discovery of new markers of cancer through serial analysis of gene expression (SAGE): prostate stem cell antigen (PSCA) is overexpressed in pancreatic adenocarcinoma. Cancer Res. 61, 4320–4324.

    PubMed  CAS  Google Scholar 

  62. Argani, P., Iacobuzio-Donahue, C., Ryu, B., et al. (2001) Mesothelin is expressed in the vast majority of adenocarcinomas of the pancreas: identification of a new cancer marker by serial analysis of gene expression (SAGE). Clin. Cancer Res. 7, 3862–3868.

    Google Scholar 

  63. Carrio, M., Mazo, A., Lopez-Iglesias, C., Estivill, X., and Fillat, C. (2001) Retrovirusmediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: implications for gene therapy. Int. J. Cancer 94, 81–88.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Christine A. Iacobuzio-Donahue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ralph H. Hruban
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Marc Ladanyi MD  & William L. Gerald MD, PhD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Iacobuzio-Donahue, C.A., Hruban, R.H. (2003). Expression Profiling of Pancreatic Ductal Adenocarcinoma. In: Ladanyi, M., Gerald, W.L. (eds) Expression Profiling of Human Tumors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-386-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-386-6_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-375-6

  • Online ISBN: 978-1-59259-386-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation